Functional Peptide-Based Biomaterials for Pharmaceutical Application: Sequences, Mechanisms, and Optimization Strategies
Journal of Functional Biomaterials · 13.01.2026 · 17 (1) · 37
DOI: 10.3390/jfb17010037 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Functional Biomaterials, online erschienen am 13.01.2026. Verfasst von Dedong Yu und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Chonnam National University, Gwangju 61186, Republic of Korea. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 221 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Ministry of Education (MOE) and the Gwangju Metropolitan Government, Chonnam National University.
Abstract (Originalsprache)
Peptide-based biomaterials have emerged as versatile tools for pharmaceutical drug delivery due to their biocompatibility and tunable sequences, yet a comprehensive overview of their categories, mechanisms, and optimization strategies remains lacking to guide clinical translation. This review systematically collates advances in peptide-based biomaterials, covering peptide excipients (cell penetrating peptides, tight junction modulating peptides, and peptide surfactants/stabilizers), self-assembling peptides (peptide-based nanospheres, cyclic peptide nanotubes, nanovesicles and micelles, peptide-based hydrogels and depots), and peptide linkers (for antibody drug-conjugates, peptide drug-conjugates, and prodrugs). We also dissect sequence-based optimization strategies, including rational design and biophysical optimization (cyclization, stapling, D-amino acid incorporation), functional motif integration, and combinatorial discovery with AI assistance, with examples spanning marketed drugs and research-stage candidates. The review reveals that cell-penetrating peptides enable efficient intracellular payload delivery via direct penetration or endocytosis; self-assembling peptides form diverse nanostructures for controlled release; and peptide linkers achieve site-specific drug release by responding to tumor-associated enzymes or pH cues, while sequence optimization enhances stability and targeting. Peptide-based biomaterials offer precise, biocompatible and tunable solutions for drug delivery, future advancements relying on AI-driven design and multi-functional modification will accelerate their transition from basic research to clinical application.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Pharmacy, Chonnam National University, Gwangju 61186, Republic of Korea.
ORCID-Profile: Seho Kweon
Förderung
- the Ministry of Education (MOE) and the Gwangju Metropolitan Government
- Chonnam National University
Zitieren
APA
Yu, D., Han, N., Son, H., Kim, S. J., & Kweon, S. (2026). Functional Peptide-Based Biomaterials for Pharmaceutical Application: Sequences, Mechanisms, and Optimization Strategies. Journal of Functional Biomaterials, 17(1), 37. https://doi.org/10.3390/jfb17010037
Vancouver
Yu D, Han N, Son H, Kim SJ, Kweon S. Functional Peptide-Based Biomaterials for Pharmaceutical Application: Sequences, Mechanisms, and Optimization Strategies. Journal of Functional Biomaterials. 2026;17(1):37. doi:10.3390/jfb17010037
BibTeX
@article{Yu2026,
author = {Yu, Dedong and Han, Nari and Son, Hyejeong and Kim, Sun Jo and Kweon, Seho},
title = {Functional Peptide-Based Biomaterials for Pharmaceutical Application: Sequences, Mechanisms, and Optimization Strategies},
journal = {Journal of Functional Biomaterials},
year = {2026},
volume = {17},
number = {1},
pages = {37},
doi = {10.3390/jfb17010037}
}
EUVIMED